BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 10877911)

  • 21. A model of GDNF gene therapy in mice with 6-Hydroxydopamine lesions: time course of Neurorestorative effects and ERK1/2 activation.
    Lindgren N; Francardo V; Quintino L; Lundberg C; Cenci MA
    J Parkinsons Dis; 2012; 2(4):333-48. PubMed ID: 23938263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons.
    Bowenkamp KE; Hoffman AF; Gerhardt GA; Henry MA; Biddle PT; Hoffer BJ; Granholm AC
    J Comp Neurol; 1995 May; 355(4):479-89. PubMed ID: 7636027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
    Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
    J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrastriatal injection of sonic hedgehog reduces behavioral impairment in a rat model of Parkinson's disease.
    Tsuboi K; Shults CW
    Exp Neurol; 2002 Jan; 173(1):95-104. PubMed ID: 11771942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Marked dopaminergic cell loss subsequent to developmental, intranigral expression of glial cell line-derived neurotrophic factor.
    Chun HS; Yoo MS; DeGiorgio LA; Volpe BT; Peng D; Baker H; Peng C; Son JH
    Exp Neurol; 2002 Feb; 173(2):235-44. PubMed ID: 11822887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopaminergic trophism after intrastriatal injection of lentivirus-transferred GDNF in Parkinson rat model.
    Sun B; Hui GZ; Guo LH; Reiser J
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):937-40. PubMed ID: 14515213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease.
    Decressac M; Ulusoy A; Mattsson B; Georgievska B; Romero-Ramos M; Kirik D; Björklund A
    Brain; 2011 Aug; 134(Pt 8):2302-11. PubMed ID: 21712347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lentiviral gene delivery of GDNF into the striatum of R6/2 Huntington mice fails to attenuate behavioral and neuropathological changes.
    Popovic N; Maingay M; Kirik D; Brundin P
    Exp Neurol; 2005 May; 193(1):65-74. PubMed ID: 15817265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurospheres modified to produce glial cell line-derived neurotrophic factor increase the survival of transplanted dopamine neurons.
    Ostenfeld T; Tai YT; Martin P; Déglon N; Aebischer P; Svendsen CN
    J Neurosci Res; 2002 Sep; 69(6):955-65. PubMed ID: 12205689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection of dopaminergic nigrostriatal afferents by GDNF delivered by microspheres in a rodent model of Parkinson's disease.
    Gouhier C; Chalon S; Aubert-Pouessel A; Venier-Julienne MC; Jollivet C; Benoit JP; Guilloteau D
    Synapse; 2002 Jun; 44(3):124-31. PubMed ID: 11954043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficient in vivo protection of nigral dopaminergic neurons by lentiviral gene transfer of a modified Neurturin construct.
    Fjord-Larsen L; Johansen JL; Kusk P; Tornøe J; Grønborg M; Rosenblad C; Wahlberg LU
    Exp Neurol; 2005 Sep; 195(1):49-60. PubMed ID: 15919076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lentiviral gene transfer to the nonhuman primate brain.
    Kordower JH; Bloch J; Ma SY; Chu Y; Palfi S; Roitberg BZ; Emborg M; Hantraye P; Déglon N; Aebischer P
    Exp Neurol; 1999 Nov; 160(1):1-16. PubMed ID: 10630186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats.
    Winkler C; Georgievska B; Carlsson T; Lacar B; Kirik D
    Neuroscience; 2006 Aug; 141(1):521-31. PubMed ID: 16697115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra.
    Salvatore MF; Zhang JL; Large DM; Wilson PE; Gash CR; Thomas TC; Haycock JW; Bing G; Stanford JA; Gash DM; Gerhardt GA
    J Neurochem; 2004 Jul; 90(1):245-54. PubMed ID: 15198683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurotensin polyplex as an efficient carrier for delivering the human GDNF gene into nigral dopamine neurons of hemiparkinsonian rats.
    Gonzalez-Barrios JA; Lindahl M; Bannon MJ; Anaya-Martínez V; Flores G; Navarro-Quiroga I; Trudeau LE; Aceves J; Martinez-Arguelles DB; Garcia-Villegas R; Jiménez I; Segovia J; Martinez-Fong D
    Mol Ther; 2006 Dec; 14(6):857-65. PubMed ID: 17015039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does neuronal expression of GDNF effectively protect dopaminergic neurons in a rat model of Parkinson's disease?
    Do Thi NA; Saillour P; Ferrero L; Paunio T; Mallet J
    Gene Ther; 2007 Mar; 14(5):441-50. PubMed ID: 17093508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenovirus-mediated transduction with human glial cell line-derived neurotrophic factor gene prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopamine depletion in striatum of mouse brain.
    Kojima H; Abiru Y; Sakajiri K; Watabe K; Ohishi N; Takamori M; Hatanaka H; Yagi K
    Biochem Biophys Res Commun; 1997 Sep; 238(2):569-73. PubMed ID: 9299553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin-binding determinants of GDNF reduce its tissue distribution but are beneficial for the protection of nigral dopaminergic neurons.
    Piltonen M; Bespalov MM; Ervasti D; Matilainen T; Sidorova YA; Rauvala H; Saarma M; Männistö PT
    Exp Neurol; 2009 Oct; 219(2):499-506. PubMed ID: 19615368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease.
    Ebert AD; Beres AJ; Barber AE; Svendsen CN
    Exp Neurol; 2008 Jan; 209(1):213-23. PubMed ID: 18061591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo.
    Tomac A; Lindqvist E; Lin LF; Ogren SO; Young D; Hoffer BJ; Olson L
    Nature; 1995 Jan; 373(6512):335-9. PubMed ID: 7830766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.